Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

MGRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

MGRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Mangoceuticals, Inc.(MGRX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Mangoceuticals, Inc.(MGRX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance Sheet

Cash Flow
Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Cash and Cash Equivalents0.70.11.50.2
Short Term Investments----
Cash and Short Term Investments0.70.11.50.2
Net Receivables---0.0
Inventory0.0---
Other Current Assets-0.00.1-
Total Current Assets0.80.11.50.2
Property, Plant & Equipment0.20.10.30.3
Long Term Investments----
Other Non-Current Assets0.0---
Total Non-Current Assets0.215.314.514.2
Total Assets1.115.416.114.4
Account Payables0.10.80.40.5
Short Term Debt-0.2--
Deferred Revenue----
Other Current Liabilities-0.4-0.2
Total Current Liabilities0.21.40.90.7
Long Term Debt----
Other Non-Current Liabilities----
Total Non-Current Liabilities0.1--0.2
Total Liabilities0.31.40.91.0
Common Stock0.00.00.00.0
Retained Earnings-11.2-20.8-40.6-44.1
Total Stockholders Equity0.813.915.213.5
Total Liabilities and Equity1.115.416.114.4

Financials

Income Statement

Balance Sheet

Cash Flow
Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Cash and Cash Equivalents0.70.11.50.2
Short Term Investments----
Cash and Short Term Investments0.70.11.50.2
Net Receivables---0.0
Inventory0.0---
Other Current Assets-0.00.1-
Total Current Assets0.80.11.50.2
Property, Plant & Equipment0.20.10.30.3
Long Term Investments----
Other Non-Current Assets0.0---
Total Non-Current Assets0.215.314.514.2
Total Assets1.115.416.114.4
Account Payables0.10.80.40.5
Short Term Debt-0.2--
Deferred Revenue----
Other Current Liabilities-0.4-0.2
Total Current Liabilities0.21.40.90.7
Long Term Debt----
Other Non-Current Liabilities----
Total Non-Current Liabilities0.1--0.2
Total Liabilities0.31.40.91.0
Common Stock0.00.00.00.0
Retained Earnings-11.2-20.8-40.6-44.1
Total Stockholders Equity0.813.915.213.5
Total Liabilities and Equity1.115.416.114.4